| ABP | acute bacterial prostatitis |
| CMS | colistin methanesulfonate |
| CNS | central nervous system |
| COL | colistin (polymyxin E) |
| CP | chronic prostatitis |
| CRE | carbapenem-resistant Enterobacterales |
| ESBL | extended-spectrum β-lactamase |
| EUCAST | European Committee on Antimicrobial Susceptibility Testing |
| FOS | fosfomycin |
| FosA | fosfomycin resistance enzyme (glutathione transferase) |
| FosB | fosfomycin resistance enzyme (bacillithiol transferase) |
| FosX | fosfomycin resistance enzyme (epoxide hydrolase) |
| GlpT | glycerol-3-phosphate transporter |
| G6P | glucose-6-phosphate |
| L-Ara4N | 4-amino-4-deoxy-L-arabinose |
| LPS | lipopolysaccharide |
| MIC | minimum inhibitory concentration |
| MDR | multidrug-resistant |
| MRSA | methicillin-resistant Staphylococcus aureus |
| MRCNS | methicillin-resistant coagulase-negative staphylococci |
| PEP | phosphoenolpyruvate |
| PEtN | phosphoethanolamine |
| PK/PD | pharmacokinetics/pharmacodynamics |
| ROS | reactive oxygen species |
| STR | streptomycin |
| TDM | therapeutic drug monitoring |
| UhpT | glucose-6-phosphate transporter |
| VAN | vancomycin |
| VRE | vancomycin-resistant enterococci |
| hVISA/VISA/VRSA | (heterogeneous) vancomycin-intermediate/vancomycin-resistant S. aureus |